A crossover RCT involving 20 adults with CFRD showed glycemic outcomes were improved using the insulin-only iLet Bionic Pancreas compared to usual care (TIR: 75% vs 62%), with no increase in hypoglycemia [102]. Here, INS is linked to Hypoglycemia.